AB862: Bill Text

AB862,5 Section 5. 51.4228 of the statutes is created to read:

AB862,4,7 51.4228 Opioid settlement moneys. For any expenditure of moneys from the opioid settlement trust fund, the employee of the department that directs opioid initiatives, or his or her designee, shall submit a proposal for the expenditure to the joint committee on finance. If the cochairpersons of the joint committee on finance do not notify the department within 14 working days after the date of the submittal of the proposed expenditure under this section that the committee has scheduled a meeting for the purpose of reviewing the proposed expenditure, the department may make the expenditure as proposed. If, within 14 working days after the date of the submittal of the proposed expenditure under this section, the cochairpersons of the committee notify the department that the committee has scheduled a meeting for the purpose of reviewing the proposed expenditure, the department may make the proposed expenditure only upon approval by the committee. The joint committee on finance may only approve expenditures that are in accordance with any applicable court order. The procedures under s. 13.10 do not apply to this section. The employee of the department that directs opioid initiatives shall oversee the expenditure of moneys from the opioid settlement trust fund. Any moneys expended from the opioid settlement trust fund may not be used for administrative expenses.

AB862,6 Section 6. 165.12 of the statutes is created to read:

AB862,4,16 165.12 Creation of opioid settlement foundation. The attorney general shall organize a nonstock, nonprofit corporation under ch. 181 for the purposes of receiving and distributing the proceeds that are attributed to future efforts to abate the opioid crisis from any judgment or settlement agreement between the state or any local governmental unit and any opioid manufacturers, opioid research associations, or any other person in the opioid industry. As a condition of receiving the proceeds of a judgment or settlement described under this section, the corporation shall meet all of the following criteria:

AB862,4,18 (1) The board of directors of the corporation is composed of all 15 of the following persons for staggered 3-year terms:

AB862,4,19 (a) To represent the interests of the state, an appointee of each of the following:

AB862,4,20 1. The attorney general.

AB862,4,21 2. The majority leader of the senate.

AB862,4,22 3. The minority leader of the senate.

AB862,4,23 4. The governor.

AB862,4,24 5. The speaker of the assembly.

AB862,4,25 6. The minority leader of the assembly.

AB862,5,2 (b) To represent the interests of the department of health services, the state, and local governmental units, an appointee of the secretary of health services.

AB862,5,5 (c) To represent the interests of the University of Wisconsin Hospitals and Clinics Authority, the state, and local governmental units, an appointee of the chief executive officer of the University of Wisconsin Hospitals and Clinics Authority.

AB862,5,7 (d) To represent the interests of the counties of this state, 2 appointees of the executive director of the Wisconsin Counties Association.

AB862,5,10 (e) To represent the interests of the counties of this state, 2 appointees that are agreed to by the Milwaukee County executive, the Dane County executive, the Waukesha County executive, and the Walworth County board of supervisors.

AB862,5,12 (f) To represent the interests of the cities of this state, 3 appointees of the executive director of the League of Wisconsin Municipalities.

AB862,5,15 (2) The articles of incorporation or bylaws of the corporation state that a purpose of the corporation is to invest, manage, and administer moneys for the purpose of abating the ongoing damages caused by the opioid epidemic.

AB862,5,18 (3) The corporation complies with open meetings laws under subch. V of ch. 19 as if the corporation is a governmental body and complies with open records law under subch. II of ch. 19 as if the corporation is an authority.

AB862,5,23 (4) The corporation authorizes no expenditure of proceeds of opioid-related judgments or settlements unless the expenditure is in accordance with any applicable court order and the expenditure is either an actual and reasonable administrative expense or is included in a comprehensive abatement plan and is consistent with any of the following purposes:

AB862,5,25 (a) Supporting clinical and evidence-based research and treatment efforts in this state to prevent and remedy opioid addiction.

AB862,6,2 (b) Supporting cost-effective opioid prevention and cessation programs, including programs that do any of the following:

AB862,6,4 1. Improve access to medications that have been proven to prevent or reverse an opioid overdose and support recovery.

AB862,6,5 2. Support peer support specialists.

AB862,6,7 3. Support screening, brief intervention, and referral to treatment services in hospitals and correctional facilities and for high-risk populations.

AB862,6,8 4. Support access to crisis beds and residential treatment services.

AB862,6,10 5. Expand and establish mobile crisis response systems and crisis stabilization centers.

AB862,6,11 6. Enforce laws regarding opioid prescriptions and sales.

AB862,6,14 7. Build provider capacity for an integrated medical home model that coordinates substance abuse treatment between regional providers that provide ongoing care.

AB862,6,16 8. Generally mitigate the growing opioid crisis through education, training, and law enforcement.

AB862,6,18 9. Improve the public health of the citizens of this state by addressing issues arising as a result of past, present, and future use of opioid pain medications.

AB862,6,22 (5) Annually, the corporation submits to the attorney general and the chairpersons of the joint committee on finance a report describing the activities of the corporation, reporting any expenditures of the corporation, and reporting any outcomes achieved by the expenditure.

AB862,6,23 (End)